News
Innovative Medicines based on
ImmunoModulatory Biologics
-
Media Room
-
News
(November 20, 2020) IMBiologics inks a worldwide exclusive licensing deal for anti-OX40L/TNF BsAb
-
- Date
- 2022-03-07 12:13:43
-
- View
- 1529
For more information, please visit : IMBiologics News (full article available in Korean)
- Prev
- There's no previous post.
- President(CEO) : Gyongsik Ha
- 260, Changnyong-daero, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea